Generic name: emtricitabine (also known as FTC) and tenofovir disoproxil
Brand names: Truvada
Class: Combined NRTI (nukes) tablets
For emtricitabine:Common: nausea, diarrhoea, headache, raised kinase levels which can cause muscle pain and weakness, skin darkening especially in children, difficulty sleeping, abnormal dreams, dizziness, vomiting, stomach pain, rash, pain. Rare: anaemia, swelling of the face, lips, tongue or throat.For tenofovir disoproxil:Common: Nausea, vomiting, diarrhoea, dizziness, low blood phosphate levels, weakness, rash, headache, stomach pains, fatigue, bloating, flatulence, liver problems. Rare: Kidney problems, bone thinning, lactic acidosis, pancreatitis, lipodystrophy.
Tablet comprises 200mg emtricitabine and 245mg tenofovir disoproxil.Take one tablet once a day.
Take with food.
*Last reviewed on 23/09/2015 Next review: 23/09/2018
Any questions? Email firstname.lastname@example.org Information included on this website was correct at the time of publication.
Data and image supplied by NAM.
Various people talk about their experiences of living with HIV.
CAB - Citizens Advice Bureau
HIV Drug Interactions
George House Trust
Equality and Human Rights Commission
Copyright 2018 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527)
Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 314-320 Gray's Inn Road, London, WC1X 8DP.